|
1
|
Takenaka K, Gemma A, Yoshimura A, Hosoya
Y, Nara M, Hosomi Y, Okano T, Kunugi S, Koizumi K, Fukuda Y, et al:
Reduced transcription of the Smad 4 gene during pulmonary
carcinogenesis in idiopathic pulmonary fibrosis. Mol Med Rep.
2:73–80. 2009.PubMed/NCBI
|
|
2
|
du Bois RM: Idiopathic pulmonary fibrosis:
Present understanding and future options. Eur Respir Rev.
20:132–133. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Olson AL, Swigris JJ, Lezotte DC, Norris
JM, Wilson CG and Brown KK: Mortality from pulmonary fibrosis
increased in the United States from 1992 to 2003. Am J Respir Crit
Care Med. 176:277–284. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Khalil N, O'Connor RN, Flanders KC and
Unruh H: TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is
differentially present in epithelial cells of advanced pulmonary
fibrosis: An immunohistochemical study. Am J Respir Cell Mol Biol.
14:131–138. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Villar J, Cabrera N, Valladares F, Casula
M, Flores C, Blanch L, Quilez M, Santana-Rodriguez N, Kacmarek R
and Slutsky A: Activation of the Wnt/b-Catenin signaling pathway by
mechanical ventilation is associated with ventilator-induced
pulmonary fibrosis in healthy lungs. PLoS One. 6:e239142012.
View Article : Google Scholar
|
|
6
|
Zhang Y, Li Y, Li Y, Li R, Ma Y, Wang H
and Wang Y: Chloroquine inhibits MGC803 gastric cancer cell
migration via the Toll-like receptor 9/nuclear factor kappa B
signaling pathway. Mol Med Rep. 11:1366–1371. 2015.
|
|
7
|
Zhang Z, Chen N, Liu JB, Wu JB, Zhang J,
Zhang Y and Jiang X: Protective effect of resveratrol against acute
lung injury induced by lipopolysaccharide via inhibiting the
myd88-dependent Toll-like receptor 4 signaling pathway. Mol Med
Rep. 10:101–106. 2014.PubMed/NCBI
|
|
8
|
Kuroiwa K, Arai T, Okazaki H, Minota S and
Tominaga S: Identification of human ST2 protein in the sera of
patients with autoimmune diseases. Biochem Biophys Res Commun.
284:1104–1108. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lax A, Sanchez-Mas J, Asensio-Lopez MC,
Fernandez-Del Palacio MJ, Caballero L, Garrido IP, Pastor-Perez FJ,
Jauzzi JL and Pascual-Figal DA: Mineralocorticoid receptor
antagonists modulate galectin-3 and interleukin-33/ST2 signaling in
left ventricular systolic dysfunction after acute myocardial
infarction. JACC Heart Fail. 3:50–58. 2015. View Article : Google Scholar
|
|
10
|
Marvie P, Lisbonne M, L'Helgoualc'h A,
Rauch M, Turlin B, Preisser L, Bourd-Boittin K, Théret N, Gascan H,
Piquet-Pellorce C and Samson M: Interleukin-33 overexpression is
associated with liver fibrosis in mice and humans. J Cell Mol Med.
14:1726–1739. 2010. View Article : Google Scholar
|
|
11
|
The Ministry of Science and Technology of
the People's Republic of China: Guidance Suggestions for the Care
and Use of Laboratory Animals. http://www.most.gov.cn/eng/pressroom/.
Accessed September 30, 2006.
|
|
12
|
Tao Z and Li HP: Comparison of mouse
pulmonary fibrosis models induced by bleomycin at different doses.
Zhongguo zuzhi gongcheng yanjiu yu linchuang kangfu. 13:1214–1218.
2009.In Chinese.
|
|
13
|
Szapiel SV, Elson NA, Fulmer JD,
Hunninghake GW and Crystal RG: Bleomycin-induced interstitial
pulmonary disease in the nude, athymic mouse. Am Rev Respir Dis.
120:893–899. 1979.PubMed/NCBI
|
|
14
|
Schmitz J, Owyang A, Oldham E, Song Y,
Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, et
al: IL-33, an Interleukin-1-like cytokine that signals via the IL-1
receptor-related protein ST2 and induces T helper type 2-associated
cytokines. Immunity. 23:479–490. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baekkevold ES, Roussigné M, Yamanaka T,
Johansen FE, Jahnsen FL, Amalric F, Brandtzaeg P, Erard M,
Haraldsen G and Girard JP: Molecular characterization of NF-HEV, a
nuclear factor preferentially expressed in human high endothelial
venules. Am J Pathol. 163:69–79. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Borish L and Steinke JW: Interleukin-33 in
Asthma: How big of a role does it play? Curr Allergy Asthma Rep.
11:7–11. 2011. View Article : Google Scholar :
|
|
17
|
Tominaga S: A putative protein of a growth
specific cDNA from BALB/c-3T3 cells is highly similar to the
extracellular portion of mouse interleukin 1 receptor. FEBS Lett.
258:301–304. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yanagisawa K, Tsukamoto T, Takagi T and
Tominaga S: Murine ST2 gene is a member of the primary response
gene family induced by growth factors. FEBS Lett. 302:51–53. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bergers G, Reikerstorfer A, Braselmann S,
Graninger P and Busslinger M: Alternative promoter usage of the
Fos-responsive gene Fit-1 generates mRNA isoforms coding for either
secreted or membrane-bound proteins related to the IL-1 receptor.
EMBO J. 13:1176–1188. 1994.PubMed/NCBI
|
|
20
|
Xu D, Chan WL, Leung BP, Huang Fp, Wheeler
R, Piedrafita D, Robinson JH and Liew FY: Selective expression of a
stable cell surface molecule on type 2 but not type 1 helper T
cells. J Exp Med. 187:787–794. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Löhning M, Stroehmann A, Coyle AJ, Grogan
JL, Lin S, Gutierrez-Ramos JC, Levinson D, Radbruch A and Kamradt
T: T1/ST2 is preferentially expressed on murine Th2 cells,
independent of interleukin 4, interleukin 5, and interleukin 10,
and important for Th2 effector function. Proc Natl Acad Sci USA.
95:6930–6935. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sandler NG, Mentink-Kane MM, Cheever AW
and Wynn TA: Global gene expression profiles during acute
pathogen-induced pulmonary inflammation reveal divergent roles for
Th1 and Th2 responses in tissue repair. J Immunol. 171:3655–3667.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rubartelli A and Lotze MT: Inside,
outside, upside down: Damage-associated molecular-pattern molecules
(DAMPs) and redox. Trends Immunol. 28:429–436. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tajima S, Oshikawa K, Tominaga S and
Sugiyama Y: The increase in serum soluble ST2 protein upon acute
exacerbation of idiopathic pulmonary fibrosis. Chest.
124:1206–1214. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
du Bois RM: Strategies for treating
idiopathic pulmonary fibrosis. Nat Rev Drug Discov. 9:129–140.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meltzer EB and Noble PW: Idiopathic
pulmonary fibrosis. Orphanet J Rare Dis. 3:82008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Selman M, King TE and Pardo A; American
Thoracic Society; European Respiratory Society; American College of
Chest Physicians: Idiopathic pulmonary fibrosis: Prevailing and
evolving hypotheses about its pathogenesis and implications for
therapy. Ann Intern Med. 134:136–151. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hayakawa H, Hayakawa M, Kume A and
Tominaga S: Soluble ST2 blocks interleukin-33 signaling in allergic
airway inflammation. J Biol Chem. 282:26369–26380. 2010. View Article : Google Scholar
|
